Re: E. David Crawford, Per-Anders Abrahamsson. PSA-based Screening for Prostate Cancer: How Does It Compare with Other Cancer Screening Tests? Eur Urol 2008;54:262–73

2009 ◽  
Vol 55 (5) ◽  
pp. e88-e89
Author(s):  
Rune Kvåle ◽  
Eivor Hernes ◽  
Freddie Bray
2013 ◽  
Vol 24 (2) ◽  
pp. 264-270 ◽  
Author(s):  
P. Carrasco-Garrido ◽  
V. Hernandez-Barrera ◽  
A. Lopez de Andres ◽  
I. Jimenez-Trujillo ◽  
C. Gallardo Pino ◽  
...  

2019 ◽  
Vol 61 (4, jul-ago) ◽  
pp. 542
Author(s):  
Martin Lajous ◽  
Matthew R Cooperberg ◽  
Jennifer Rider ◽  
Hugo Arturo Manzanilla-García ◽  
Fernando Bernardo Gabilondo-Navarro ◽  
...  

 Prostate-specific antigen (PSA)-based early detection for prostate cancer is the subject of intense debate. Imple­mentation of organized prostate cancer screening has been challenging, in part because the PSA test is so amenable to opportunistic screening. To the extent that access to cancer screening tests increases in low- and middle-income countries (LMICs), there is an urgent need to thoughtfully evaluate existing and future cancer screening strategies to ensure benefit and control costs. We used Mexico’s prostate cancer screening efforts to illustrate the challenges LMICs face. We provide five considerations for policymakers for a smarter approach and implementation of PSA-based screening. 


2021 ◽  
pp. 096914132199942
Author(s):  
Austin Snyder ◽  
Sean Jang ◽  
Ilana S Nazari ◽  
Avik Som ◽  
Efren J Flores ◽  
...  

The COVID-19 pandemic has led to delays in cancer diagnosis, in part due to postponement of cancer screening. We used Google Trends data to assess public attention to cancer screening during the first peak of the COVID-19 pandemic. Search volume for terms related to established cancer screening tests (“colonoscopy,” “mammogram,” “lung cancer screening,” and “pap smear”) showed a marked decrease of up to 76% compared to the pre-pandemic period, a significantly greater drop than for search volume for terms denoting common chronic diseases. Maintaining awareness of cancer screening during future public health crises may decrease delays in cancer diagnosis.


2019 ◽  
Vol 2 (3) ◽  
pp. e191156 ◽  
Author(s):  
Shivan J. Mehta ◽  
Rebecca S. Pepe ◽  
Nicole B. Gabler ◽  
Mounika Kanneganti ◽  
Catherine Reitz ◽  
...  

2018 ◽  
Vol 12 ◽  
Author(s):  
Azra Izanloo ◽  
Kamran Ghaffarzadehgan ◽  
Fahimeh Khoshroo ◽  
Maryam Erfani Haghiri ◽  
Sara Izanloo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document